Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume 276, Issue 2, Pages 154-170
Publisher
Wiley
Online
2014-03-05
DOI
10.1111/joim.12229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transduction with the Antioxidant Enzyme Catalase Protects Human T Cells against Oxidative Stress
- (2014) T. Ando et al. JOURNAL OF IMMUNOLOGY
- Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF- 1
- (2014) H. Li et al. JOURNAL OF IMMUNOLOGY
- Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
- (2014) P. Sinha et al. JOURNAL OF IMMUNOLOGY
- Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg
- (2013) A. S. Baur et al. BLOOD
- Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
- (2013) Felix Klug et al. CANCER CELL
- Macrophage Regulation of Tumor Responses to Anticancer Therapies
- (2013) Michele De Palma et al. CANCER CELL
- The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer
- (2013) Nicola E. Annels et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
- (2013) Ang Huang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-Derived Suppressor Cells as Osteoclast Progenitors: A Novel Target for Controlling Osteolytic Bone Metastasis
- (2013) A. Sawant et al. CANCER RESEARCH
- Melanoma-Educated CD14 + Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms
- (2013) Yumeng Mao et al. CANCER RESEARCH
- Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
- (2013) A. Kanerva et al. CLINICAL CANCER RESEARCH
- Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway
- (2013) Dehong Yan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
- (2013) Bastian Schilling et al. INTERNATIONAL JOURNAL OF CANCER
- STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
- (2013) David Vasquez-Dunddel et al. JOURNAL OF CLINICAL INVESTIGATION
- Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
- (2013) Rikke B. Holmgaard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Association of Myeloid-derived Suppressor Cells and Efficacy of Cytokine-induced Killer Cell Immunotherapy in Metastatic Renal Cell Carcinoma Patients
- (2013) Zibing Wang et al. JOURNAL OF IMMUNOTHERAPY
- The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses
- (2013) Bryan D Bell et al. NATURE IMMUNOLOGY
- Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
- (2013) Y. P. de Coana et al. Cancer Immunology Research
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
- (2012) Lauren J. Bayne et al. CANCER CELL
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
- (2012) Yuliya Pylayeva-Gupta et al. CANCER CELL
- Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
- (2012) G. Pietra et al. CANCER RESEARCH
- On the armament and appearances of human myeloid-derived suppressor cells
- (2012) Isabel Poschke et al. CLINICAL IMMUNOLOGY
- Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase
- (2012) Margit Lanzinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Myeloid-derived Suppressor Cells Adhere to Physiologic STAT3- vs STAT5-dependent Hematopoietic Programming, Establishing Diverse Tumor-Mediated Mechanisms of Immunologic Escape
- (2012) Peter A. Cohen et al. IMMUNOLOGICAL INVESTIGATIONS
- Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance
- (2012) Theodore S. Johnson et al. IMMUNOLOGICAL INVESTIGATIONS
- PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells
- (2012) Nataša Obermajer et al. IMMUNOLOGICAL INVESTIGATIONS
- S100A9 a new marker for monocytic human myeloid-derived suppressor cells
- (2012) Fei Zhao et al. IMMUNOLOGY
- Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
- (2012) L. Wang et al. JOURNAL OF IMMUNOLOGY
- Uveal Melanoma: The Inflammatory Microenvironment
- (2012) Inge H.G. Bronkhorst et al. Journal of Innate Immunity
- High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis
- (2012) Dimitrios Mougiakakos et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation
- (2012) D Mougiakakos et al. LEUKEMIA
- S100A9 and tumor growth
- (2012) Tomas Leanderson et al. OncoImmunology
- Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients
- (2012) Jana de Boniface et al. OncoImmunology
- Inflammation restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation
- (2011) C. H. M. J. Van Elssen et al. BLOOD
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer
- (2011) Carmen Timke et al. BMC CANCER
- A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer
- (2011) Christoph Reissfelder et al. BMC CANCER
- Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines
- (2011) I. Poschke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
- (2011) M. Fujita et al. CANCER RESEARCH
- COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps
- (2011) Y. Nakanishi et al. CARCINOGENESIS
- Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function
- (2011) J. De Boniface et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
- (2011) Tangying Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
- (2011) Barbara Molon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
- (2011) C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Immunosuppressive CD14+HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
- (2010) Y. Lin et al. BLOOD
- Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress
- (2010) D. Mougiakakos et al. BLOOD
- COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
- (2010) Joris D Veltman et al. BMC CANCER
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy
- (2010) A. G. Sikora et al. CLINICAL CANCER RESEARCH
- Role of prostaglandin E2 in peptidoglycan mediated iNOS expression in mouse peritoneal macrophages in vitro
- (2010) Yogesh Dahiya et al. FEBS LETTERS
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells
- (2010) Evgeniy Eruslanov et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
- (2010) M. K. Brimnes et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The many roles of NOX2 NADPH oxidase-derived ROS in immunity
- (2010) Grace Y. Lam et al. Seminars in Immunopathology
- Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia
- (2010) Anna Martner et al. Expert Review of Hematology
- Arginase: an emerging key player in the mammalian immune system
- (2009) Markus Munder BRITISH JOURNAL OF PHARMACOLOGY
- NADPH Oxidase 4 Contributes to Transformation Phenotype of Melanoma Cells by Regulating G2-M Cell Cycle Progression
- (2009) M. Yamaura et al. CANCER RESEARCH
- Inhibition of Superoxide Generation upon T-Cell Receptor Engagement Rescues Mart-127-35-Reactive T Cells from Activation-Induced Cell Death
- (2009) H. Norell et al. CANCER RESEARCH
- Cox-2 expression in ovarian malignancies
- (2009) Joseph Menczer European Journal of Obstetrics & Gynecology and Reproductive Biology
- PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-β signaling during mammary tumorigenesis
- (2009) Maozhen Tian et al. FASEB JOURNAL
- Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells
- (2009) Moses K. Donkor et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A cross-sectional analysis of physical activity and obesity indicators in European participants of the EPIC-PANACEA study
- (2009) H Besson et al. INTERNATIONAL JOURNAL OF OBESITY
- Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14−/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer
- (2009) Chien-Ying Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
- Immunosuppressive CD14+HLA-DRlow/−monocytes in prostate cancer
- (2009) Stanimir Vuk-Pavlović et al. PROSTATE
- TGF-β and kynurenines as the key to infectious tolerance
- (2009) Maria L. Belladonna et al. TRENDS IN MOLECULAR MEDICINE
- Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
- (2009) Per Björk et al. PLOS BIOLOGY
- Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death
- (2008) D. Mougiakakos et al. BLOOD
- Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma
- (2008) C. Christian Johansson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- l-Arginine as a factor increasing arginase significance in diagnosis of primary and metastatic colorectal cancer
- (2008) Wojciech Graboń et al. CLINICAL BIOCHEMISTRY
- Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02
- (2008) G. E. Peoples et al. CLINICAL CANCER RESEARCH
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
- (2008) Pingyan Cheng et al. JOURNAL OF EXPERIMENTAL MEDICINE
- shRNA-targeted Cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells
- (2008) Rui Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started